BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir Read more
Remdesivir, tocilizumab being considered for ‘restricted use’ on severely ill COVID-19 patients Read more
Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients Read more